It is essential for pharmacists to understand and educate patients about the profiles and administration techniques of the various types of treatments.
Given indications that the government will continue to focus on the pharmaceutical industry, pharmacies should prepare to deal with future allegations of FCA wrongdoing.
This major global health problem can result in liver damage, chronic conditions, and mortality, but pharmacists can raise awareness and promote preventive measures, such as vaccination.
Adherence to the complex therapeutic regimen required after transplantation is critical for decreasing or preventing rejection episodes.
Recent guidelines recommend this new option, a soluble guanylate cyclase agonist, for use in certain patients with this cardiovascular condition.